» Articles » PMID: 33633588

The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection

Overview
Journal Front Physiol
Date 2021 Feb 26
PMID 33633588
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The scale of the SARS-CoV-2 pandemic has thrust a spotlight on the sex-based differences in response to viral diseases; morbidity and mortality are greater in men than women. We outline the mechanisms by which being female offers a degree of protection from COVID19, that persists even when confounders such as comorbidities are considered. The physiological and immunological mechanisms are fascinating and range from incomplete X chromosome inactivation of immune genes, a crucial role for angiotensin converting enzyme 2 (ACE2), and regulation of both immune activity and ACE2 by sex steroids. From this flows understanding of why lung and other organs are more susceptible to COVID19 damage in men, and how their distinct immunological landscapes need to be acknowledged to guide prognosis and treatment. Pregnancy, menopause, and hormone replacement therapy bring changed hormonal environments and the need for better stratification in COVID19 studies. We end by noting clinical trials based on increasing estrogens or progesterone or anti-testosterone drugs; excellent examples of translational physiology.

Citing Articles

Sex differences in airway disease: estrogen and airway surface liquid dynamics.

Harvey B, McElvaney N Biol Sex Differ. 2024; 15(1):56.

PMID: 39026347 PMC: 11264786. DOI: 10.1186/s13293-024-00633-z.


Estradiol and Dihydrotestosterone Levels in COVID-19 Patients.

MacArthur T, Goswami J, Ramachandran D, Price-Troska T, Lundell K, Ballinger B Mayo Clin Proc. 2023; 98(4):559-568.

PMID: 36872195 PMC: 9842620. DOI: 10.1016/j.mayocp.2022.12.018.


Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors.

Zsichla L, Muller V Viruses. 2023; 15(1).

PMID: 36680215 PMC: 9863423. DOI: 10.3390/v15010175.


Does comorbidity burden explain the higher COVID-19 mortality risk among men? A retrospective cross-sectional analysis of a well-defined cohort of patients in Bronx, New York.

Vasa A, Kini M, Neugarten J, Bellin E, Golestaneh L BMJ Open. 2022; 12(9):e063862.

PMID: 36581961 PMC: 9437736. DOI: 10.1136/bmjopen-2022-063862.


Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study.

Lopez-Rodriguez R, Ruiz-Hornillos J, Corton M, Almoguera B, Minguez P, Perez-Tomas M Andrology. 2022; 11(1):24-31.

PMID: 36375449 PMC: 10098487. DOI: 10.1111/andr.13339.


References
1.
Mauvais-Jarvis F, Klein S, Levin E . Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes. Endocrinology. 2020; 161(9). PMC: 7438701. DOI: 10.1210/endocr/bqaa127. View

2.
Hillmer A, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt F . Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet. 2005; 77(1):140-8. PMC: 1226186. DOI: 10.1086/431425. View

3.
Speyer C, Rancilio N, McClintock S, Crawford J, Gao H, Sarma J . Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol. 2005; 288(4):C881-90. DOI: 10.1152/ajpcell.00467.2004. View

4.
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

5.
Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K . Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19. Hypertens Res. 2020; 43(8):837-840. PMC: 7237878. DOI: 10.1038/s41440-020-0478-1. View